US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.640
  • +0.010+0.13%
Close Aug 16 16:00 ET
  • 7.640
  • 0.0000.00%
Post 20:02 ET
1.58BMarket Cap-10465P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
32.54%109.33M
34.87%92.76M
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
37.77%68.78M
72.31%270.83M
68.68%79.55M
84.97%75.83M
Operating revenue
32.54%109.33M
34.87%92.76M
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
38.38%68.78M
72.31%270.83M
68.68%79.55M
84.97%75.83M
Cost of revenue
82.53%1.73M
48.40%1.39M
-29.31%4.66M
-34.42%1.64M
-68.56%1.14M
284.62%950K
294.12%938K
-9.22%6.59M
495.70%2.5M
487.48%3.61M
Gross profit
31.96%107.6M
34.68%91.37M
23.66%326.75M
19.10%91.76M
18.54%85.61M
24.90%81.54M
36.54%67.84M
76.27%264.23M
64.85%77.05M
78.84%72.21M
Operating expense
-3.33%98.84M
9.98%105.86M
4.31%430.46M
8.98%134.43M
8.78%97.53M
2.24%102.24M
-3.40%96.26M
25.96%412.67M
24.71%123.36M
5.53%89.66M
Selling and administrative expenses
20.03%61.21M
24.02%59.36M
34.21%213.89M
28.37%64.38M
37.19%50.65M
34.14%51M
39.63%47.87M
34.13%159.37M
41.73%50.15M
5.51%36.92M
Research and development costs
-26.58%37.62M
-3.92%46.49M
-14.50%216.57M
-4.31%70.05M
-11.11%46.88M
-17.33%51.25M
-25.97%48.39M
21.31%253.3M
15.23%73.21M
5.54%52.74M
Operating profit
142.32%8.76M
49.01%-14.49M
30.13%-103.71M
7.86%-42.67M
31.67%-11.92M
40.37%-20.7M
43.12%-28.42M
16.48%-148.44M
11.24%-46.31M
60.87%-17.45M
Net non-operating interest income expense
15.84%-21.18M
14.75%-20.48M
1.60%-92.46M
15.31%-20.12M
-0.63%-23.16M
-7.48%-25.17M
-0.99%-24.02M
-58.64%-93.97M
-26.58%-23.75M
-63.16%-23.02M
Non-operating interest income
-5.23%3.55M
19.33%4.03M
207.72%15.78M
65.13%4.47M
137.73%4.18M
515.76%3.75M
6,155.56%3.38M
8,169.35%5.13M
19,214.29%2.7M
19,455.56%1.76M
Non-operating interest expense
-14.46%24.73M
-10.55%24.51M
9.23%108.24M
-7.09%24.58M
10.37%27.35M
20.37%28.92M
14.93%27.4M
67.12%99.09M
40.88%26.46M
75.52%24.78M
Other net income (expense)
99.71%-84K
77.73%-51K
-1,415.78%-30.06M
73.29%-374K
-36.99%-737K
-21,856.06%-28.72M
-29.38%-229K
-103.60%-1.98M
-102.53%-1.4M
-384.68%-538K
Gain on sale of security
-127.91%-84K
77.73%-51K
47.60%-1.04M
73.29%-374K
-36.99%-737K
128.03%301K
-29.38%-229K
-185.32%-1.98M
-232.54%-1.4M
-384.68%-538K
Special income (charges)
--0
----
---29.02M
--0
--0
---29.02M
----
--0
--0
--0
-Less:Other special charges
----
----
--29.02M
--0
----
--29.02M
----
----
----
----
Income before tax
83.24%-12.5M
33.51%-35.01M
7.43%-226.23M
11.62%-63.16M
12.63%-35.82M
-28.59%-74.59M
28.76%-52.66M
-34.42%-244.38M
-360.29%-71.47M
30.28%-41M
Income tax
-76.76%172K
-45.60%365K
-88.66%310K
-1,982.89%-1.43M
-78.32%330K
-13.55%740K
140.50%671K
21.30%2.73M
-96.63%76K
1.52M
Net income
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
Net income continuous Operations
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
Minority interest income
Net income attributable to the parent company
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
Basic earnings per share
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
30.30%-0.23
Diluted earnings per share
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
30.30%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 32.54%109.33M34.87%92.76M22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M37.77%68.78M72.31%270.83M68.68%79.55M84.97%75.83M
Operating revenue 32.54%109.33M34.87%92.76M22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M38.38%68.78M72.31%270.83M68.68%79.55M84.97%75.83M
Cost of revenue 82.53%1.73M48.40%1.39M-29.31%4.66M-34.42%1.64M-68.56%1.14M284.62%950K294.12%938K-9.22%6.59M495.70%2.5M487.48%3.61M
Gross profit 31.96%107.6M34.68%91.37M23.66%326.75M19.10%91.76M18.54%85.61M24.90%81.54M36.54%67.84M76.27%264.23M64.85%77.05M78.84%72.21M
Operating expense -3.33%98.84M9.98%105.86M4.31%430.46M8.98%134.43M8.78%97.53M2.24%102.24M-3.40%96.26M25.96%412.67M24.71%123.36M5.53%89.66M
Selling and administrative expenses 20.03%61.21M24.02%59.36M34.21%213.89M28.37%64.38M37.19%50.65M34.14%51M39.63%47.87M34.13%159.37M41.73%50.15M5.51%36.92M
Research and development costs -26.58%37.62M-3.92%46.49M-14.50%216.57M-4.31%70.05M-11.11%46.88M-17.33%51.25M-25.97%48.39M21.31%253.3M15.23%73.21M5.54%52.74M
Operating profit 142.32%8.76M49.01%-14.49M30.13%-103.71M7.86%-42.67M31.67%-11.92M40.37%-20.7M43.12%-28.42M16.48%-148.44M11.24%-46.31M60.87%-17.45M
Net non-operating interest income expense 15.84%-21.18M14.75%-20.48M1.60%-92.46M15.31%-20.12M-0.63%-23.16M-7.48%-25.17M-0.99%-24.02M-58.64%-93.97M-26.58%-23.75M-63.16%-23.02M
Non-operating interest income -5.23%3.55M19.33%4.03M207.72%15.78M65.13%4.47M137.73%4.18M515.76%3.75M6,155.56%3.38M8,169.35%5.13M19,214.29%2.7M19,455.56%1.76M
Non-operating interest expense -14.46%24.73M-10.55%24.51M9.23%108.24M-7.09%24.58M10.37%27.35M20.37%28.92M14.93%27.4M67.12%99.09M40.88%26.46M75.52%24.78M
Other net income (expense) 99.71%-84K77.73%-51K-1,415.78%-30.06M73.29%-374K-36.99%-737K-21,856.06%-28.72M-29.38%-229K-103.60%-1.98M-102.53%-1.4M-384.68%-538K
Gain on sale of security -127.91%-84K77.73%-51K47.60%-1.04M73.29%-374K-36.99%-737K128.03%301K-29.38%-229K-185.32%-1.98M-232.54%-1.4M-384.68%-538K
Special income (charges) --0-------29.02M--0--0---29.02M------0--0--0
-Less:Other special charges ----------29.02M--0------29.02M----------------
Income before tax 83.24%-12.5M33.51%-35.01M7.43%-226.23M11.62%-63.16M12.63%-35.82M-28.59%-74.59M28.76%-52.66M-34.42%-244.38M-360.29%-71.47M30.28%-41M
Income tax -76.76%172K-45.60%365K-88.66%310K-1,982.89%-1.43M-78.32%330K-13.55%740K140.50%671K21.30%2.73M-96.63%76K1.52M
Net income 83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M
Net income continuous Operations 83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M
Minority interest income
Net income attributable to the parent company 83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M
Basic earnings per share 85.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.3830.30%-0.23
Diluted earnings per share 85.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.3830.30%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg